Online citations, reference lists, and bibliographies.
← Back to Search

Formulary Availability And Regulatory Barriers To Accessibility Of Opioids For Cancer Pain In Europe: A Report From The ESMO/EAPC Opioid Policy Initiative.

N. Cherny, J. Baselga, F. de Conno, L. Radbruch
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Many patients in Europe do not receive adequate relief of pain because of excessive regulatory restrictions on the availability and accessibility of opioids. This is a major public health problem. The aim of the study is to evaluate and report on opioid availability and the legal and regulatory barriers to accessibility across the countries of Europe. METHODS European Society for Medical Oncology and European Association for Palliative Care national representatives reported data regarding survey of opioid availability and accessibility. Formulary adequacy is evaluated relative to the World Health Organization (WHO) essential drugs list and the International Association for Hospice and Palliative Care list of essential medicines for palliative care. Overregulation is evaluated according to the guidelines for assessment of national opioid regulations of the WHO. RESULTS Data were reported on the availability and accessibility of opioids for the management of cancer pain in 21 Eastern European countries and 20 Western European countries. Results are presented describing the availability and cost of opioids for cancer pain in each surveyed country and nine forms of regulatory restrictions. CONCLUSIONS Using standards derived from the WHO and International Narcotics Control Board, this survey has exposed formulary deficiencies and excessive regulatory barriers that interfere with appropriate patient care in many European countries. There is an ethical and public health imperative to address these issues.
This paper references
18. International Narcotics Control Board. Single Convention on Narcotic Drugs
(1961)
Report of the International Narcotic Control Board for
(2007)
10.1046/J.1365-2354.2003.00325.X
Italy reforms national policy for cancer pain relief and opioids.
C. Blengini (2003)
A Clinical Guide to Supportive and Palliative Care for HIV/AIDS
O. O’Neill (2003)
10.1016/B978-0-444-86236-5.50087-0
UNITED NATIONS ECONOMIC AND SOCIAL COUNCIL
Frederic L. Kirgis (1983)
10.1016/J.JPAINSYMMAN.2007.02.006
Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care.
L. de Lima (2007)
10.5144/0256-4947.1996.358B
Book review: National cancer control programmes, policies and managerial guidelines.
A. Ezzat (1996)
10.1016/J.JPAINSYMMAN.2007.02.013
Ensuring opioid availability: methods and resources.
D. Joranson (2007)
10.1016/j.jpainsymman.2008.03.011
Barriers to the development of palliative care in the countries of Central and Eastern Europe and the Commonwealth of Independent States.
T. Lynch (2009)
Availability of Opiates for Medical Needs: Report of the International Narcotics Control Board for 1995
(1996)
World Health Organization. Access to Controlled Medications Programme
(2007)
10.1016/J.JPAINSYMMAN.2007.02.022
Palliative care as an international human right.
F. Brennan (2007)
10.1016/S0885-3924(02)00464-5
Poland: cancer pain and palliative care.
J. Luczak (2002)
World Health Organization Achieving Balance in National Opioids Control Policy: Guidelines for Assessment
(2000)
10.1016/S0140-6736(07)61173-8
Right to the highest attainable standard of health
P. Hunt (2007)
Section 63 of the Health and Social Care Act
(2001)
World Health Organization. National Cancer Control Programmes: Policies and Managerial Guidelines, 2nd edition
(2002)
The selection and use of essential medicines.
P. Kazembe (2009)
10.1177/0269216306072058
The international association for hospice and palliative care list of essential medicines for palliative care.
D. Doyle (2006)
Safer Management of Controlled Drugs: The Government’s Response to the Fourth Report of the Shipman Inquiry
D Blunkett (2004)
Safer Management of Controlled Drugs: The Government's Response to the Fourth Report of the Shipman Inquiry. London: Her Majesty's Government
D Blunkett (2004)
International Narcotics Control Board. Availability of Opiates for Medical Needs: Report of the International Narcotics Control Board for 1995
(1996)
10.1016/J.JPAINSYMMAN.2007.02.023
Romania: changing the regulatory environment.
D. Moşoiu (2007)
10.1093/ANNONC/MDL073
Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering.
N. Cherny (2006)
International Narcotics Control Board. Demand for and Supply of Opiates for Medical and Scientific Needs
(1989)
Recommendation Rec (2003) 24 of the Committee of Ministers to member states on the organisation of palliative care and explanatory memorandum
Europe Council Of (2003)
World Health Organization. Palliative Care
(2007)
Role of the nurse in resourcelimited settings
J Downing
Achieving Balance in National Opioids Control Policy: Guidelines for Assessment
(2000)
10.1213/01.ane.0000268145.52345.55
Pain Management: A Fundamental Human Right
F. Brennan (2007)
10.1186/1741-7015-8-8
Access to pain treatment as a human right
D. Lohman (2010)
World Health Organization. Palliative Care. Geneva, Switzerland: World Health Organization
(2007)
10.1016/S0140-6736(06)68482-1
Reform of drug control policy for palliative care in Romania
D. Moşoiu (2006)
10.1111/J.1526-4637.2006.00255.X
Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
J. Inciardi (2007)
Role of the Nurse in Resource-Limited Settings
J. Downing (2006)
Section 63 of the Health and Social Care Act 2001. London: Her Majesty's Government
(2001)
Annals of Oncology original article
(2010)
International Narcotics Control Board Report of the International Narcotic Control Board for 1999, Freedom from Pain and Suffering
(1999)
Report of the International Narcotic Control Board for 1999, Freedom from Pain and Suffering
(1999)
10.18356/ab50fcbd-en
International Narcotics Control Board
Ciencias Políticas (2011)
10.1016/j.jpainsymman.2009.03.007
Improving availability of and access to opioids in Colombia: description and preliminary results of an action plan for the country.
M. Leon (2009)
10.1093/ANNONC/MDL373
International Association for Hospice and Palliative Care list of essential medicines for palliative care
L. Lima (2006)



This paper is referenced by
10.36076/ppj.2018.3.219
Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005-2016.
B. Fischer (2018)
10.3109/15360288.2013.847517
The Impact of an Aging Population on Palliative Care
Tony O'brien (2013)
10.1016/B978-0-323-08340-9.00005-0
The Health-Care Policy of Pain Management
T. R. Vetter (2013)
10.4324/9781315742205
The Routledge Handbook of Philosophy of Pain
Jennifer Corns (2017)
10.1016/j.jpainsymman.2013.01.014
Consensus building on access to controlled medicines: a four-stage Delphi consensus procedure.
S. Jünger (2013)
10.31662/jmaj.2020-0037
Prefectural Adequacy of Opioid Availability for Cancer Pain and Its Determinants in Japan: A Preliminary Study
K. Azuma (2020)
10.1002/nau.23867
Opioid prescribing practices and medication use following urogynecological surgery
S. Solouki (2019)
10.1016/j.jpainsymman.2013.03.015
Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006.
Béatrice Duthey (2014)
10.1016/j.jpainsymman.2014.02.013
Legal barriers in accessing opioid medicines: results of the ATOME quick scan of national legislation of eastern European countries.
Marjolein J M Vranken (2014)
10.22270/JDDT.V2I3.190
Combination of Natural Drugs: An Emerging Trend in Cancer Chemotherapy
S. Kumar (2012)
10.1200/JCO.2015.61.0733
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain.
E. Bandieri (2016)
10.1016/j.jamda.2013.04.009
Treatment of pain in European nursing homes: results from the Services and Health for Elderly in Long TERm Care (SHELTER) study.
A. Lukas (2013)
10.1093/annonc/mds084
Palliative cancer care in Middle Eastern countries: accomplishments and challenges.
M. Silbermann (2012)
10.1007/s00520-013-1746-2
A cross-sectional survey of pain in palliative care in Portugal
F. Gonçalves (2013)
10.1016/j.jpainsymman.2012.02.014
Trends in the consumption of opioid analgesics in Taiwan from 2002 to 2007: a population-based study.
Hsueh-Hsing Pan (2013)
10.1371/currents.RRN1304
Current Pharmacological Management in Juvenile Huntington’s Disease
L. Robertson (2012)
10.1111/add.12224
Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?
B. Fischer (2014)
10.1016/j.critrevonc.2011.06.002
End-of-life care across Southern Europe: a critical review of cultural similarities and differences between Italy, Spain and Portugal.
A. Meñaca (2012)
10.22391/920.287410
Palyatif bakım servisinde yatan akciğer kanserli hastaların narkotik analjezik kullanımı
H. Can (2016)
10.1093/ANNONC/MDS233
Management of cancer pain: ESMO Clinical Practice Guidelines.
C. Ripamonti (2012)
10.1111/dar.12539
Revisiting the 'paradigm shift' in opioid use: Developments and implications 10 years later.
B. Fischer (2018)
10.1093/annonc/mdq224
Management of cancer pain: ESMO Clinical Practice Guidelines.
L. Jost (2010)
10.1016/j.jpainsymman.2015.08.012
A Systematic Content Analysis of Policy Barriers Impeding Access to Opioid Medication in Central and Eastern Europe: Results of ATOME.
Eugenia Larjow (2016)
10.1186/s40545-018-0138-x
Provider preferences for postoperative analgesia in obese and non-obese patients undergoing ambulatory surgery
A. Bui (2018)
10.1089/JPM.2016.0290
International Association for Hospice and Palliative Care Position Statement: Euthanasia and Physician-Assisted Suicide
De LimaLiliana (2017)
10.1007/s40140-015-0123-8
Perioperative Implications of the Global Cancer Epidemic
K. McQueen (2015)
10.1097/NJH.0b013e31829307e5
Evaluation of Therapeutic Choices for the Treatment of Pain in the Terminal Oncologic Patient Before and During Hospice Admission
M. Zago (2013)
10.1503/cmaj.160356
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures
B. Fischer (2016)
10.1177/0269216309360103
Access to therapeutic opioid medications in Europe by 2011? Fifty years on from the Single Convention on Narcotic Drugs
J. Cleary (2010)
10.2165/11642230-000000000-00000
US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids
S. Mercadante (2012)
10.1007/s40122-017-0072-7
Chronic Non-Cancer Pain Management Capacity in Karachi
S. F. Lakha (2017)
10.1177/0269216312461973
Multivariate analysis of countries’ government and health-care system influences on opioid availability for cancer pain relief and palliative care: More than a function of human development
A. Gilson (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar